Molecular analysis of CD133-positive circulating tumor cells from patients with metastatic castration-resistant prostate cancer.
Molecular analysis of CD133-positive circulating tumor cells from patients with metastatic castration-resistant prostate cancer. J Transl Sci. 2015 Jul; 1(1).